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ReviewChemical Genetics: Adding to the
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and their use as new probes in the study of develop-
mental biological questions (see Table 1). Although a
chemical genetic approach offers great potential in facil-
Jing-Ruey J. Yeh1 and Craig M. Crews1,2,*
1Department of Molecular, Cellular and
Developmental Biology
2 Departments of Chemistry and Pharmacology itating developmental biological studies, the numbers
of compounds that have an effect on embryonic devel-Yale University
New Haven, Connecticut 06520 opment is small. Therefore, we will also discuss recent
examples of high-throughput screens to identify new
compounds that modulate embryonic development
(Figure 2). Finally, on the basis of the current knowledgeRecent advances in cell and molecular biology have
generated important tools to probe developmental of cell culture techniques and cell marker expression
profiling, it is now possible to probe the fundamentalquestions. In addition, new genetic model systems
such as Danio rerio now make large-scale vertebrate processes underlying cell differentiation and dedifferen-
tiation in tissue culture systems with small moleculesearly developmental mutant screens feasible. None-
theless, some developmental questions remain diffi- (see Table 2). Some of these examples will also be pre-
sented.cult to study because of the need for finer temporal,
spatial, or tuneable control of gene function within a
developmental system. New uses for old teratogens Use of Signaling Pathway-Specific Probes
as well as novel chemical modulators of development to Dissect Developmental Processes
have begun to fill this void. Cyclopamine
One natural teratogen that has proven useful in the in-
Interface of Chemistry and Developmental vestigation of a key developmental pathway is the alka-
Biology: Chemical Genetics Concept loid cyclopamine isolated from the California corn lily
The use of small molecules to affect biological phenom- (Veratrum californicum). Lambs born to ewes that had
ena, also known as chemical genetics, has made a sig- ingested this wildflower during pregnancy displayed
nificant impact in diverse areas of biology (Crews and multiple birth defects, most notably holoprosencephaly
Splittgerber, 1999; Koh and Crews, 2002; Schreiber, (HPE), characterized by an absence of midline facial
1998). The majority of these biologically active com- structures and cyclopia (Keeler, 1978). The teratogenic
pounds are potent, specific inhibitors of known intracel- effects of cyclopamine on domestic livestock have been
lular signaling pathways. However, the identification of known for decades, but only recently has the molecular
small molecules with very specific biological properties, mechanism of action of Veratrum californicum been re-
but unknown intracellular targets, can also reveal signifi- ported to act via inhibition of the sonic hedgehog (Shh)
cant insights into various biological questions. The im- pathway. Like cyclopamine-treated embryos, Shh/
pact of biologically active small molecules has been mouse embryos also display pronounced craniofacial
greatest in the study of those processes that are lacking defects (Chiang et al., 1996). This similar HPE phenotype
model systems easily investigated with genetics. In ad- led Beachy and colleagues to explore the potential inhi-
dition, the ability to control the timing of addition of bition of the Shh pathway by cyclopamine (Cooper et
these compounds to a system has afforded a greater al., 1998). Using a chick embryo explant system, Beachy
temporal control of gene function than is possible with and colleagues demonstrated that cyclopamine blocked
conventional genetic manipulations. Given that animal the Shh-mediated induction of floor plate cells in respon-
development is a sequence of highly regulated events sive tissue (neural plate ectoderm) expressing the Shh
requiring expression of key players at the right place, receptor Patched (Ptc).
the right time, and the right levels, the use of small Cyclopamine has been useful in the study of Shh sig-
molecule “conditional alleles” has great potential for the naling underlying organogenesis. Presumptive pancre-
modulation of early embryonic processes. atic tissue arising from gastrointestinal endoderm lacks
The intersection of biologically active small molecules Shh expression, unlike adjacent tissue that will give rise
and developmental biology has had an inauspicious his- to the stomach and duodenum. This observation and
tory. The teratogenic potential of specific compounds the finding that forced expression of Shh in this tissue
found in dyes, foods, the environment, and pharmaceuti- blocked normal pancreatic development (Apelqvist et
cals was well recognized by the early twentieth century. al., 1997) led to the hypothesis that inhibition of Shh is
Although small molecules have long been used to study critical for rendering gastrointestinal endoderm compe-
embryonic development, traditional teratogenic re- tent for pancreas development (Hebrok et al., 1998; Kim
search has generally provided little information about and Melton, 1998). Testing this hypothesis, Kim and
the molecular mechanisms underlying developmental Melton incubated chicken embryos with cyclopamine in
processes. This is due in large part to the fact that, ovo to inhibit Shh signaling. Thirty percent of embryos
unlike genetic mutations, the molecular targets of these treated at stage 11 with 0.5–1.0 mg of cyclopamine dis-
compounds are generally unknown. Here we review the played heterotopic pancreatic cells. Thus, the use of
recent identification of specific signaling modulators this specific Shh signaling inhibitor confirmed the impor-
tance of Shh signaling repression in pancreatic organo-
genesis.*Correspondence: craig.crews@yale.edu
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Table 1. Signaling Pathway Modulators
Chemical Activity Pathway References
cyclopamine antagonist (direct ligand of Smoothened) sonic hedgehog (Shh) signaling Cooper et al. (1998)
Hg-Ag 1.2 agonist (direct ligand of Smoothened) sonic hedgehog (Shh) signaling Frank-Kamenetsky et al. (2002)
disuphiram inhibitor of the conversion of retinol to RA retinoid acid (RA) signaling Gould et al. (1998)
BMS493 antagonist of RA receptors retinoid acid (RA) signaling Dupe and Lumsden (2001)
DAPT inhibitor of -secretase Notch signaling Micchelli et al. (2003)
PTK787/ZK22258 antagonist of VEGF receptors VEGF signaling Chan et al. (2002)
SU5402 antagonist of FGF and VEGF receptors FGF and VEGF singaling Poss et al. (2000)
Several natural and synthetic compounds with known signal transduction modulatory activities have been used to explore questions in
vertebrate embryogenesis.
Since the discovery of its critical role in mediating apparent ligand for the membrane protein Patched (Ptc),
which, in turn, inhibits another membrane protein,autopodal anterior-posterior patterning activity of the
zone of polarizing activity (ZPA), much attention has Smoothened (Smo), it was important to determine the
level within this signaling pathway where Hg-Ag 1.2focused on modulating Shh activity in various develop-
mental systems. Urodele amphibians are unique among acted. Chemical epistasis studies with cyclopamine in-
dicated that Hg-Ag1.2 acts at the same level as cyclo-tetrapod vertebrates in their ability to regenerate lost
limbs throughout their lives. Axolotls are a good system pamine, most likely as a direct ligand of Smo. Direct
binding of this class of Shh agonists to the heptahelicalfor studying limb pattern regeneration, but a genetic
approach to this question in this system is not tractable. bundle of Smo was independently demonstrated with a
photoaffinity analog (Chen et al., 2002). Additional ShhFortunately, a chemical genetic approach is proving
fruitful. Roy and Gardiner recently demonstrated that antagonists have also been reported (Chen et al., 2002),
all of which were shown to bind to Smo directly butcyclopamine administration to regenerating axolotl
limbs results in loss of digits (Roy and Gardiner, 2002). affect its function differently. These different chemical
alleles of Smo function may provide much needed in-This chemically induced malformation phenocopies
digit loss observed in Shh knockout mice, demonstra- sights into the mechanisms by which Ptc inhibits Smo,
Hh relieves this inhibition, and/or Smo activates down-ting the conservation of Shh signaling during limb regen-
eration in urodeles, as in primary limb development in stream signaling events.
Retinoic Acid Receptor Pathwayother vertebrates.
Both loss-of-function and gain-of-function mutations in Hindbrain Patterning
Possible roles for the physiological morphogen all trans-are important in genetic studies of an individual gene.
Likewise, the identification of small molecule antago- retinoic acid (RA) have been proposed for a number of
years. While some of the proposed roles for RA havenists as well as agonists can aid the functional dissection
of signaling pathways. Toward this goal, in addition to proved controversial, a growing consensus is emerging
in recent years for the involvement of RA in hindbraincyclopamine’s use as a Shh antagonist, several Hedge-
hog signaling agonists have been identified with a cell- and spinal cord development. RA joins several other
signaling molecules such as Wnt proteins and FGFs inbased assay. Screening 140,000 synthetic compounds
for small molecules capable of upregulating the Gli pro- possible involvement of CNS posteriorization. Verte-
brate hindbrain anterior-posterior patterning is knownmoter, Frank-Kamenetsky and coworkers (Frank-
Kamenetsky et al., 2002) identified an active chloro- to depend upon Hox gene expression in segmental do-
mains. Retinoid deficiency has been known to resultbenzothiopene-containing compound, which was fur-
ther refined to yield the SHH agonist Hg-Ag 1.2. Studies in misregulation of Hox gene expression in the caudal
hindbrain of quail embryos. In addition, exogenous addi-showed that Hg-Ag 1.2 treatment could partially rescue
the midline defects in Shh/ embryos. Since SHH is an tion of RA induces ectopic Hox expression, resulting in
Table 2. Small Molecule Modulators of Cellular Differentiation
Chemical Target Activity References
trichostatin A (TSA) histone deacetylases inhibits oligodendrocyte Marin-Husstege et al. (2002)
differentiation
5-aza-cytidine (5-azaC) cytosine-5-DNA methyl- promotes cardiomyocyte Rangappa et al. (2003); Xu et
transferase differentiation al. (2002)
T0070907 peroxisome proliferator- inhibits adipocyte Lee et al. (2002)
activated receptor  differentiation
purmorphamine unknown promotes osteoblast Wu et al. (2002)
differentiation
TWS119 glycogen synthase induces neuronal differentia- Ding et al. (2003)
kinase-3 tion in embryonic stem cells
myoseverin unknown promotes dedifferentiation Rosania et al. (2000)
of myotubes into myoblast
Compounds known to influence cell fate determination have proven useful in the exploration of lineage commitment and dedifferentiation.
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posterior rhombomere transformation (Grapin-Botton et can substitute for genetic manipulations and potentially
have the advantage of finer temporal control over proteinal., 1998). The molecular basis for this RA-induced regu-
lation was shown to act via the early neural enhancer function.
Nevertheless, DAPT was not able to fully elicit the(Early NE), a cis-regulatory element found in several Hox
loci (Gould et al., 1998). Furthermore, transgenic studies defects observed in Notch genetic mutants. These other
phenotypes, which include an increased number of bris-showed that the Early NE faithfully reproduces the tem-
poral and spatial anterior boundary of HoxB4 expression tles on the notum, defects in leg segmentation, and
small eyes, were only seen at a low frequency upon(Gould et al., 1998). Using a murine explant culture sys-
tem, Krumlauf and colleagues demonstrated that parax- DAPT treatment. In addition, some degree of lethality
at high concentrations of DAPT were found, which mayial mesoderm tissue (i.e., somites) provide a transient
signal that induces Hoxb4 expression in the neural plate be related to the reduced Notch activity and the require-
ments of Notch for viability. However, other explanations(Gould et al., 1998). This signal is blocked upon treat-
ment with disuphiram, which inhibits the conversion of for these findings may include a particular pharmacoki-
netic property of DAPT in flies, such as the uptake,retinol to RA, thus implicating RA in this signaling. Mean-
while, the somite-generated inductive signal could be metabolism, and distribution of the compound in differ-
ent parts of the organism. The possibility that this com-mimicked both spatially and temporally by pulsatile ad-
dition of RA. pound may be associated with a toxicity not related
to Notch signaling also exists. All of these factors areGiven the wide differences of hindbrain phenotypes
previously observed in various models of retinoic acid important concerns when a chemical genetic approach
is employed. The incomplete inhibition of the functiondeficiency, Dupe and Lumsden investigated the tempo-
ral regulation of RA signaling in hindbrain patterning of a protein can be either beneficial or undesired. In the
case of a protein that plays an important role in multiple(Dupe and Lumsden, 2001). Using an inhibitor (Bristol-
Myers Squibb compound 493) of all three retinoic acid developmental pathways, and, thus, a straight null muta-
tion leads to pleiotropic effects, a chemical genetic ap-receptors, RA signaling was blocked in a staged series
of chick embryos at sequential points during develop- proach equivalent to either a temporal or spatial condi-
tional allele will be likely desirable.ment. The results indicated that RA is needed for the
specification of rhombomere boundaries from stage 5 The discovery that therapeutics designed to treat Alz-
heimer’s disease can affect the Notch signaling pathwayto 10. Interestingly, this RA dependency is lost in an
anterior to posterior progression as development pro- may also have an impact on the future drug design for
amyloid-related diseases or some cancers associatedgresses. Moreover, the authors were able to vary the
penetrance of this phenotype by varying the concentra- with aberrant Notch activity. It is not yet known whether
DAPT can inhibit Notch processing in the adult flies.tion of antagonist administered, thereby reproducing
the phenotype observed in animals displaying vitamin However, it is conceivable that, while chemicals can
substitute genetic mutations in developmental biology,A deficiency (VAD). The application of various concen-
trations of antagonist also showed that proper pat- the developing model organisms can also help identify
potential pharmacological agents.terning of posterior rhombomere boundaries requires
progressively higher concentration of endogenous RA. Pharmacological Analyses of Zebrafish VEGF
and FGF Signaling PathwaysThis result strengthens the hypothesis that a complex
retinoid gradient acts to pattern the posterior hindbrain. The use of Danio rerio for genetic analysis of embryonic
development has several advantages over other genetic-secretase-Notch Pathway
Many lines of evidence have suggested that the prese- model systems. The fact that the early ex utero develop-
ment is rapid and transparent greatly facilitates analysisnilin (PS)-dependent transmembrane-cleaving activity
required for processing and releasing the intracellular of mutant embryonic phenotypes. In addition, Danio re-
rio offers the ability to study complex vertebrate devel-domain of Notch receptor is similar to the -secretase
proteolysis of the amyloid- (A) precursor protein. opmental processes such as angiogenesis and organo-
genesis. Moreover, a reverse genetic manipulation ofTherefore, Micchelli and coworkers (Micchelli et al.,
2003) recently tested whether A-lowering -secretase developmental processes is possible in zebrafish
through injection of morpholino antisense oligonucleo-inhibitors designed for the treatment of Alzheimer’s dis-
ease would phenocopy developmental defects in Dro- tides (MO) into the early embryo. However, MO injection
results in an early and sustained inhibition of gene func-sophila Notch mutants. They found that the -secretase
inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-(S)-phe- tion and, thus, is less useful for those studies requiring
fine temporal control.nylglycine t-butyl ester (DAPT) can block Notch signaling
both in the mammalian cell culture system and in flies. The permeability of zebrafish embryos to small mole-
cules offers the possibility of using a chemical geneticMeanwhile, the progeny of adult flies exposed to DAPT
displayed an identical wing-notching phenotype to that approach to study vertebrate developmental questions.
This has best been demonstrated with potent and selec-of mutant Notch flies as well as other morphological
defects consistent with perturbation of Notch signaling. tive protein kinase inhibitors. For example, addition of
a vascular endothelial growth factor receptor (VEGFR)This wing phenotype was also shown to be dependent
on the time of compound administration. Notch is known inhibitor (PTK787/ZK222584) to developing zebrafish
embryos blocks major blood vessel development, a phe-to be required for proper wing development during the
third larval instar. Only larvae transiently exposed to notype also observed upon loss of VEGF ligand function
induced by MO injection. Since PTK787/ZK222584 isDAPT during the fourth day of development developed
the Notch wing phenotype. These studies demonstrate a reversible competitor, the authors were also able to
perform drug washout experiments that permitted a finethat a small molecule manipulation of protein function
Developmental Cell
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dissection of VEGF’s temporal regulation (Chan et al.,
2002). Likewise, treatment of fish embryos with a broad-
spectrum protein kinase C inhibitor, PKC412, pheno-
copied the unique body axis curvature observed in the
zebrafish atypical PKC mutant heart and soul (has)
(Horne-Badovinac et al., 2001). In addition, in zebrafish
fin regeneration studies, SU5402, a potent inhibitor of
fibroblast growth factor (FGF) and vascular endothelial
growth factor (VEGF) receptors has been shown to block
blastema formation and msx-1 expression without af-
fecting the wound-healing site (Poss et al., 2000). These
results are consistent with the known role of FGFs in
limb regeneration and development (Dungan et al., 2002;
Han et al., 2001; Niswander et al., 1994). A role for FGF
in patterning of the central nervous system was also
confirmed with SU5402. Upon exposure of developing
zebrafish embryos to this kinase inhibitor, the telenceph-
alon was induced properly; however, the subsequent
development of the subpallial telencephalon was inhib-
ited, indicating a need for FGF signaling in establishing
telencephalon regionalization (Shinya et al., 2001). Given
its specificity and cell permeability, this compound has
found additional uses in the investigations of FGFs in
various developmental processes, such as otic vesicle
development, neural cell fate determination, and retinal
ganglion cell development in different systems (Maroon
et al., 2002; McCabe et al., 1999; Minokawa et al., 2001;
Wilson et al., 2001).
Figure 1. Zebrafish Small Molecule Developmental Screening Pro-Unfortunately, no model system is perfect. In the case
cedure (Peterson et al., 2000)
of STI571, a potent inhibitor of both c-Abl and c-Kit
kinases fails to phenocopy the c-kit genetic mutant,
the procedure may be streamlined, theoretically, witheven though the zebrafish c-Kit homolog is quite con-
more-specific readouts (i.e., with transgenic fish con-served relative to mammalian c-kit (Chan et al., 2002;
taining a reporter gene).Parichy et al., 1999). In addition, we have found that
Screening for small molecule developmental modula-
bathing zebrafish embryos with TNP-470, a potent anti-
tors, Schreiber and colleagues identified compounds
angiogenesis inhibitor that is being used in clinical trials
that modulate one of four systems that differ signifi-
against cancers, results in embryo developmental de-
cantly between vertebrates and invertebrates, i.e., the
fects only at a very low frequency. Although the drug
central nervous system, the cardiovascular system, pig-
binding pocket of MetAP-2 (methionine aminopepti-
mentation, and the ear (Peterson et al., 2000). For exam-
dase-2), the cellular target of TNP-470 (Sin et al., 1997), ple, one compound, 31J6 (Figure 2), was found to cause
is well conserved between human and zebrafish and 2:1, instead of 1:1, atrium to ventricle contraction ratios.
the phenotypes elicited from TNP-470 treatment indeed Interestingly, this phenotype is similar to a human car-
correspond to MetAP-2 morpholino injection, the reason diovascular condition called second-degree atrioven-
of such low penetrance from drug treatment is not yet tricular heart block. In addition, compound 31B4 (Figure
known (J.-R.J.Y. and C.M.C., unpublished data). There- 2) was found to block the production of pigment, but
fore, in addition to concerns about lack of protein homol- not the specification or migration of melanocytes. The
ogy or signaling pathway conservation between differ- structural similarity between 31B4 and phenylthiourea
ent species, the factors such as drug uptake, (PTU), a tyrosinase inhibitor commonly used in blocking
metabolism, and distribution mentioned above should pigment production, suggests that 31B4 is a potent in-
be considered when contemplating a chemical genetic hibitor of tyrosinase. On the other hand, small molecule
approach to a developmental question. 33N14-treated fish appeared to lose their pigmentation
because of a differentiation blockage from neural crest
Chemical Genetic Screens for Small Molecule cells into melanocytes or because of proliferation inhibi-
Developmental Modulators tion (Figure 2). Further analysis of one compound (31N3)
While the examples above illustrate a reverse genetic (Figure 2) that specifically affects ear development
approach with small molecule inhibitors of known tar- showed that treated embryos do not develop the small,
gets, the zebrafish model also affords the possibility bony otolith structure that is physically linked to hair
of a forward genetic screen for compounds targeting cell bundles within the ear, despite the proper develop-
unknown proteins. Figure 1 is a simplified scheme of a ment of the otic vesicles. Since these structures respond
phenotypic chemical screening with zebrafish embryos. to gravity and help maintain balance, 31N3-treated fish
Because of the small size of zebrafish embryos, the often swim on their sides or upside down. Again, the
whole screening procedure can be virtually automated advantage of using small molecules as conditional al-
leles was exploited by adding or washing away 31N3 atwith only small quantities of the chemicals. In addition,
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in many tissues, manifested in the heart by the formation
of the ventricle within the atrium (Peterson et al., 2001).
Interestingly, Peterson et al. identified the biaryl com-
pound they named concentramide (Figure 2), which also
induces ventricle formation within the atrium upon nano-
molar treatment of zebrafish embryos. Moreover, con-
centramide induces this concentric heart chamber phe-
notype without widespread disruption of the epithelia,
thus strongly suggesting that at least two separate path-
ways can regulate the polarity of cardiac tube assembly
during atrial and ventricular cell fate determination.
The above example illustrates that chemical screens
may complement genetic screens. When a genetic mu-
tation results in early lethality or pleiotropic effects or
when mutations are masked by redundancy, a chemical
genetic approach may provide an alternative solution.
Theoretically, compounds that only partially inhibit pro-
tein functions can be identified. For example, TNP-470
that targets MetAP-2 as mentioned above only inhibits
the proteolytic activity of MetAP-2, but it does not block
the role of MetAP-2 in protein translation (Griffith et
al., 1997). Meanwhile, chemicals that can block multiple
functional isoforms at once, such as various kinase in-
hibitors, can be informative about the function of a gene
family. Although many of these results can be achieved
with traditional genetic screens, chemical screens offer
several distinct advantages: they are relatively inexpen-
sive, do not require long-term breeding, and offer the
possibility of scaling up and automation. The chemical
genetic approach can also be used in combination with
genetic mutants in genetic enhancer or suppressor
screens. For example, the gridlock zebrafish mutant de-
Figure 2. Small Molecules Affecting Zebrafish Development
velops a blockade in the anterior blood flow that resem-
Compounds identified from a chemical library on the basis of their
bles a human congenital cardiovascular malformation.ability to modulate heart, pigment, or ear development in zebrafish
In both cases, coarctation of the aorta occurs, and sur-embryos (Peterson et al., 2000).
vival is dependent on development of the collateral ves-
sels and reconstituting the blood flow. A chemical sup-
pressor screen has been used to find small molecules
various time points during development. These studies
that can revert the defects caused by the mutation in
showed that the period between 14 and 26 hr postfertil- the gridlock gene (in Congenital Heart Defects: Small
ization (hpf) is a crucial window for otolith development. Molecules Provide Answers by T.A. Peterson, R.T. Pe-
These results demonstrate the feasibility of a large-scale terson, and M.C. Fishman, presented at the 2003 Annual
chemical genetic screen for small molecule modulators Meeting of the Americal Association of Anatomists in
of developmental processes. San Diego, CA.). Such molecules may not only help
Several small molecules identified from this screening elucidate the etiology of this developmental malforma-
appear to phenocopy other genetic mutants. For in- tion, but may also directly benefit the treatment of hu-
stance, the heart phenotype caused by 31J6 treatment man patients.
phenocopies breakdance mutants. In addition, the ear One major concern of a chemical genetic approach
defects caused by 31N3 phenocopy keinstein and empty is the target specificity of any small molecule biological
ear mutants. It is possible that these compounds target modulator. Unlike the identification of a genetic mutation
proteins involved in the same signaling pathways as where the completion of various genome projects has
perturbed by genetic lesion in these mutant fish strains. greatly accelerated the cloning process, the identifica-
Epistasis studies between genetic mutants and chemi- tion and validation of the target(s) of a small molecule
cal-treated mutants can also provide useful information are sometimes more difficult. Occasionally, a candidate
regarding the drug target and the signaling pathways. gene approach may arise from epistasis studies, tran-
However, it is also possible that independent pathways scriptome studies, or studies of the downstream ef-
are needed for a particular developmental process. An- fectors. In addition, target(s) may be identified through
other compound that arose from such a forward chemi- rigorous biochemical purification. Before the target(s)
cal approach has provided a new tool in the study of are identified and validated, it is imperative that the
cardiac organogenesis. As mentioned above, the mu- specificity and the reproducibility of the phenotypes
tant heart and soul is a loss-of-function of PKC. In suggest that the compound indeed has specific tar-
addition to the pronounced body axis curvature, has get(s). For example, the lack of any additional develop-
mutant fish also display heart developmental defects. mental malformation upon treatment of fish with con-
centrations three orders of magnitude higher thanHas fish have disrupted epithelial cell-cell interactions
Developmental Cell
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needed to induce the phenotype demonstrated specific- DNA Methylation
DNA methylation is another example of epigenetic con-ity of concentramide for the cardiac organogenesis. In
addition, the effect of structural modifications on the trol of gene expression that is believed to play a role in
cell lineage commitment during development. Cytosinecompound’s efficacy may be another indication of its
specificity. For example, failure of structure-activity rela- methylation of CpG dinucleotides is the most common
form of DNA methylation in vertebrates. Cytosine-5-DNAtionship (SAR) studies to identify structural elements
on the compound that correlate with biological activity methyltransferase (MTase) is responsible for both the
establishment and maintenance of this stable, heritablemight suggest that more nonspecific properties of the
compound (i.e., amphipathicity and hydrophobicity) are DNA modification, which is believed to increase gene
silencing via the recruitment of transcriptional repres-responsible for the observed phenotype. Most impor-
tantly, since developmental screens use embryos to sors (Newell-Price et al., 2000).
The role of DNA methylation during the cell differentia-measure the effects of the compounds, reproducibility
between individual embryos and even embryos from tion process has been widely demonstrated through the
use of 5-aza-cytidine (5-azaC), a nucleotide analog thatdifferent strain backgrounds ensures the significance
of the drug effects. For instance, all the compounds induces DNA hypomethylation. For example, it has been
shown that the adult mesenchymal stem cells isolatedidentified from the screens mentioned above have been
tested in three different zebrafish strains, and they in- from fatty tissue can be differentiated into cardiomyo-
cytes through 5-azaC treatment (Rangappa et al., 2003).duced similar phenotypes in all backgrounds, with the
exception of 31N3. The transformed cells not only express myosin heavy
chain, -actinin, and troponin-I, but they also form a
ball-like structure and start to contract spontaneouslyProbing the Cellular Basis of Development
in culture. In another study, Carpenter and colleagueswith Small Molecules
also found that 5-aza-deoxycytidine, but not DMSO orHistone Acetylation
retinoic acid, can enhance the differentiation ofWhile small molecules have only recently begun to be
cardiomyocytes from human embryonic stem cells (Xuof use to developmental biologists at the macroscopic
et al., 2002). Therefore, these results strongly suggestlevel, biologically active compounds have for years pro-
that DNA demethylation is involved in the cardiomyocytevided insights at the cellular level into developmental
cell lineage commitment.processes such as cell fate determination. Epigenetic
Transcription Factor Agonists and Antagonistscontrol of chromatin remodeling has been shown in re-
While small molecule inhibitors of DNA methylation andcent years to play an important role in cellular differentia-
histone deacetylation have global transcriptional ef-tion. For instance, histone acetylation on lysine residues
fects, chemical agonists and antagonists of selectedis associated with chromatin regions of transcriptional
transcription factors offer the ability to influence geneactivity, while deacetylation, through the action of his-
expression with finer resolution. One such transcriptiontone deacetylases (HDACs), is associated with tran-
factor is the peroxisome proliferator-activated receptorscriptional repression (Kiermaier and Eilers, 1997). Much
 (PPAR). A member of the nuclear hormone receptorhas been learned about this process through the devel-
opment and use of specific HDAC inhibitors such as superfamily of ligand-activated transcription factors,
PPAR has been the focus of pharmaceutical attention,trichostatin A (TSA) and trapoxin (Yoshida et al., 1995).
For example, the use of cell cycle inhibitors had shown given its role in adipocyte differentiation. PPAR is the
molecular target of the thiazolidinedione class of antidia-that inhibition of proliferation was necessary, but not
sufficient, for the differentiation of neuronal precursor betic compounds, including rosiglitazone, troglitazone,
and pioglitazone. These PPAR agonists increase insu-cells into oligodendrocytes (Tang et al., 1999; Tikoo et
al., 1998). Given the significant level of chromatin remod- lin sensitivity and reduce glycemia, lipidemia, and insu-
linemia in patients with type 2 diabetes (Dubois et al.,eling that accompanies cellular differentiation, Marin-
Husstege and colleagues hypothesized that histone 2002). Recently, a selective nonthiazolidinedione PPAR
ligand, T0070907, has been described (Lee et al., 2002).acetylation played a role in oligodendrocyte differentia-
tion (Marin-Husstege et al., 2002). Using synchronized This small molecule antagonist was shown to compete
for rosiglitazone binding via covalent modification ofprimary neonatal rat cortical progenitors induced to dif-
ferentiate into oligodendrocytes, the authors showed PPAR. Moreover, T0070907 blocks the cell differentia-
tion of the adipogenic cell line 3T3-L1 in response tothat there is a temporal window during which histone
deacetylation is correlated with the acquisition of a insulin or PPAR agonists such as rosiglitazone. This
increasing palette of PPAR small molecule modulatorsbranched morphology and myelin gene expression. The
importance of histone deacetylation was demonstrated provides powerful tools for dissecting the molecular
events underlying adipogenesis.with the HDAC inhibitor TSA, which blocked oligoden-
drocyte differentiation. TSA-treated progenitors were Chemical Screens for Cellular Differentiation
and Dedifferentiationable to exit from the cell cycle but did not progress
to oligodendrocytes. Interestingly, the authors showed In the recent years, cell-based chemical screens for
biological modulators have been used in several disci-that TSA blocked differentiation only when administered
during a specific temporal window. The ability of HDAC plines. For example, because of the clinical potential of
autologous cell replacement, Schultz and colleaguesinhibitors to inhibit oligodendrocyte differentiation is cell
lineage dependent, since TSA did not affect these pre- screened for small molecules capable of inducing differ-
entiation of multipotent mesenchymal progenitor cellscursor cells’ ability to differentiate into astrocytes. These
results suggest that transcriptional repression is a cru- into oesteoblast lineage. From a heterocycle combinato-
rial chemical library (Ding et al., 2002), they identified acial event during oligodendrocyte lineage progression.
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compound, purmorphamine, that can induce the ex- In addition, a small molecule approach offers the ability
pression of osteogenesis marker alkaline phosphatase to control protein function in developmental model sys-
and transcription factor Cbfa1/Runx2 (Wu et al., 2002). tems such as the chick and Xenopus laevis, in which
Furthermore, the combination of purmorphamine and genetic approaches are cumbersome. One of the great-
BMP-4 can induce the transdifferentiation of preadipo- est advantages provided by small molecule develop-
cytes and myoblasts to osteoblasts synergistically. mental modulators is the immediate temporal control
Thus, purmorphamine can serve as a chemical probe and precise dosage of protein function. This control
to study the molecular mechanism underlying bone de- allows one to identify the critical timing necessary for
velopment. Another screen set out to understand the gene function and developmental events, often in the
process of cell fate determination in embryonic stem presence of multiple functional isoforms of a gene.
(ES) cells. In this case, they discovered TWS119, a 4,6- Chemical genetic approaches also have limitations.
disubstituted pyrrolopyrimidine that could induce neu- While they are highly compatible with some develop-
ronal differentiation in pluripotent murine embryonal car- mental model systems, they are not as useful in other
cinoma (EC) cells and ES cells. Interestingly, they found systems because of the challenges of compound admin-
that transient, but not prolonged, incubation of this small istration (e.g., in utero in the mouse and across the C.
molecule resulted in a higher percentage of neurons. elegans cuticle). In addition, unlike genetic mutations,
This finding suggests that early differentiation signals it is sometimes a challenge to determine whether a small
must be shut off during later stages of maturation. Fur- molecule indeed has a specific target, which renders
thermore, TWS119 has been shown to bind glycogen pleiotropic effects, or whether it simply possesses non-
synthase kinase-3with TWS119-linked agarose affinity specific toxicity.
matrices. These data, together with other reports, have In recent years, several advances have allowed for a
implicated Wnt signaling in neuronal induction from ES greater use of small molecules in developmental biol-
cells (Aubert et al., 2002; Tang et al., 2002). ogy. The number of chemical substances known to have
In addition to probing the molecular basis of differenti- an effect on embryonic development has been small,
ation, small molecules are also beginning to play a role which has limited the widespread use of this chemical
in the investigation of cellular dedifferentiation. Screen- genetic approach. In addition, the lack of cellular target
ing for compounds that influence dedifferentiation, identification of these biologically active compounds
Schultz and colleagues again identified a small molecule has hampered their use and study. While target identifi-
capable of inducing a morphological reversion of differ- cation remains a significant obstacle, many efforts have
entiated myotubes from a multinucleate to mono- been made, and a systematic approach is starting to
nucleate myoblast-like morphology (Rosania et al., form toward this end (King, 1999). Additionally, advances
2000). Dubbed myoseverin for its myotube fragmenta- in chemical library synthesis and the availability of com-
tion activity, this 2,6,9-trisubstituted purine was shown mercial small molecule libraries have made high-through-
to induce microtubule disassembly without affecting put small molecule developmental screens feasible.
other cytoskeletal elements. However, other small mole- Moreover, small molecule probes have been increas-
cule microtubule modulators such as Taxol had no mor- ingly useful to study cell differentiation and dedifferenti-
phological reversal activity on myotubes. In vitro assays ation in cell culture systems. The future of the intersec-
also demonstrated myoseverin’s ability to inhibit micro- tion between chemical biology and developmental
tubule polymerization. Recent studies have shown that biology will undoubtedly lie in additional screens for
myotubes transiently treated with myoseverin and then small molecule developmental modulators as well as
subsequently incubated with growth factors can prolif- the identification of new inhibitors of given signaling
erate and are capable of undergoing myotube differenti- pathways. As these compounds are identified and be-
ation again (Perez et al., 2002). Interestingly, the authors
come readily available, the palette of tools available
report that this cycle of myotube differentiation/dediffer-
to the developmental biologist for manipulating gene
entiation could be repeated up to ten times with no
function will certainly grow.observable cellular damage. Using myoseverin to toggle
between myoblast differentiation states, the authors ex-
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